Le Lézard
Classified in: Health, Science and technology, Business
Subjects: CON, ACC, ANW

AquiNovo Raises US$1.5 Million from Neovia


MISGAV, Israel, Nov. 27, 2017 /PRNewswire/ -- AquiNovo Ltd. ("AquiNovo"), a portfolio company of The Trendlines Group ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced that it signed an agreement with Neovia for an aggregate investment of US$1.5 million.

AquiNovo Logo

Aquaculture is a fast-growing market with increasing economic opportunities. Increase in the world's population, particularly in Africa, Asia, and Latin America, and rising standards of living is estimated to result in a 60% increase in world production of animal proteins by 2040. Aquaculture production, which currently represents 4% of world animal protein production (41 million tonnes), is expected to grow by 450% in the next two decades. Due to a high feed conversion rate, aquaculture is a very effective system for protein production, in particular in emerging markets with limited purchasing power.

The aquaculture industry today needs sustainable solutions that provide higher yields, with lower production costs and reduced exposure to risks associated with longer growth periods. Bearing this in mind, Neovia has defined "intensive aquaculture" as one of its five global priority innovation fields and has implemented a holistic approach in innovative solutions for aquaculture.

Similarly, AquiNovo's technology addresses this challenge by developing solutions to improve farmed fish development. The company offers a non-GMO, non-hormonal, easy-to-use solution to be incorporated into the fish feed, providing hatcheries and fish farms with shorter time to market and additional growth cycles within existing infrastructure. Founded in 2015, AquiNovo is based in Misgav, Israel.

AquiNovo's CEO, Dr. Nissim Chen, remarked, "We believe that AquiNovo's technology will make a real difference for fish farmers world-wide. The combination of fish yield enhancement, with reduced exposure to risks associated with longer growth periods, will significantly contribute to risk management and revenues for fish farmers. Neovia's investment affirms their confidence in the Company, its vision and its achievements to date. We're excited to work with Neovia on the development of innovative solutions for the aquaculture market."

Hubert de Roquefeuil, President of Neovia, added, "Intensive aquaculture ranks among our five major innovation fields and we are very interested in collaborating with a recognized partner such as AquiNovo. Our strong position in the international aquaculture market, especially in Tilapia, will deeply benefit from this differentiating and innovative technology."

Contact:
Nissim Chen, CEO
AquiNovo Ltd.
+972-54-24-87-223
[email protected]
www.aquinovo.com

 

Neovia logo

SOURCE AquiNovo Ltd


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:45
Fluency, the leading innovator of digital advertising management and automation solutions for agencies and large enterprises, announced today that it earned the number one ranking in the small business category...

at 10:31
Gulfstream Aerospace Corp., a wholly owned subsidiary of General Dynamics , today announced the all-new Gulfstream G700 has received Federal Aviation Administration (FAA) type certification, paving the way for customer deliveries of the most spacious...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....



News published on and distributed by: